TR200302001T4 - ''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler'' - Google Patents

''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler''

Info

Publication number
TR200302001T4
TR200302001T4 TR2003/02001T TR200302001T TR200302001T4 TR 200302001 T4 TR200302001 T4 TR 200302001T4 TR 2003/02001 T TR2003/02001 T TR 2003/02001T TR 200302001 T TR200302001 T TR 200302001T TR 200302001 T4 TR200302001 T4 TR 200302001T4
Authority
TR
Turkey
Prior art keywords
pyrido
preparation
methods
pharmaceutical compositions
compositions containing
Prior art date
Application number
TR2003/02001T
Other languages
English (en)
Turkish (tr)
Inventor
Goldstein Solo
Poissonnet Guillaume
Parmentier Jean-Gilles
Lestage Pierre
Lockhart Brian
Original Assignee
Les Labora Tories Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Labora Tories Servier filed Critical Les Labora Tories Servier
Publication of TR200302001T4 publication Critical patent/TR200302001T4/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR2003/02001T 2001-07-12 2002-07-11 ''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler'' TR200302001T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0109260A FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
TR200302001T4 true TR200302001T4 (tr) 2004-01-21

Family

ID=8865405

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/02001T TR200302001T4 (tr) 2001-07-12 2002-07-11 ''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler''

Country Status (24)

Country Link
US (1) US6992085B2 (enExample)
EP (1) EP1275647B1 (enExample)
JP (1) JP3950018B2 (enExample)
KR (1) KR100485020B1 (enExample)
CN (1) CN1197863C (enExample)
AR (1) AR036166A1 (enExample)
AT (1) ATE254124T1 (enExample)
AU (1) AU2002300094B2 (enExample)
BR (1) BR0202681A (enExample)
CA (1) CA2394027C (enExample)
DE (1) DE60200089T2 (enExample)
DK (1) DK1275647T3 (enExample)
EA (1) EA005160B1 (enExample)
ES (1) ES2210219T3 (enExample)
FR (1) FR2827288B1 (enExample)
HU (1) HUP0202282A3 (enExample)
MX (1) MXPA02006699A (enExample)
NO (1) NO322966B1 (enExample)
NZ (1) NZ520120A (enExample)
PL (1) PL355034A1 (enExample)
PT (1) PT1275647E (enExample)
SI (1) SI1275647T1 (enExample)
TR (1) TR200302001T4 (enExample)
ZA (1) ZA200205596B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004089410A1 (ja) * 2003-04-03 2006-07-06 協和醗酵工業株式会社 神経因性疼痛の予防及び/または治療剤
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0512567A (pt) * 2004-06-22 2008-03-25 Pfizer Prod Inc compostos antagonistas de receptor de histamina-3 diazabicìclico e respectivas composições farmacêuticas
CN103110635A (zh) * 2005-07-04 2013-05-22 海波因特制药有限责任公司 组胺h3受体拮抗剂
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
WO2007106349A2 (en) * 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
KR100871691B1 (ko) 2006-10-16 2008-12-05 삼성전자주식회사 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치
EP3495363B1 (en) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect
CA3089498A1 (en) 2018-01-26 2019-08-01 Shionogi & Co., Ltd. Condensed ring compounds having dopamine d3 receptor antagonistic effect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
GB8518236D0 (en) * 1985-07-19 1985-08-29 Beecham Group Plc Compounds
WO1994006794A1 (en) * 1992-09-24 1994-03-31 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
ATE344249T1 (de) * 1999-07-19 2006-11-15 Merck Frosst Canada Ltd Pyrazinone, diese verbindungen enthaltende zusammenstellungen

Also Published As

Publication number Publication date
CN1397557A (zh) 2003-02-19
HUP0202282A2 (hu) 2003-03-28
CN1197863C (zh) 2005-04-20
SI1275647T1 (en) 2004-02-29
ZA200205596B (en) 2003-03-27
US6992085B2 (en) 2006-01-31
CA2394027C (fr) 2008-01-08
ES2210219T3 (es) 2004-07-01
PT1275647E (pt) 2004-03-31
HU0202282D0 (enExample) 2002-09-28
HK1050682A1 (en) 2003-07-04
FR2827288B1 (fr) 2003-10-31
EP1275647A1 (fr) 2003-01-15
EA200200663A1 (ru) 2003-02-27
NO20023345L (no) 2003-01-13
NZ520120A (en) 2004-03-26
AU2002300094B2 (en) 2007-06-14
EP1275647B1 (fr) 2003-11-12
BR0202681A (pt) 2003-05-06
AR036166A1 (es) 2004-08-18
HUP0202282A3 (en) 2003-11-28
DE60200089D1 (de) 2003-12-18
US20030195216A1 (en) 2003-10-16
DK1275647T3 (da) 2004-03-15
JP3950018B2 (ja) 2007-07-25
DE60200089T2 (de) 2004-09-09
KR100485020B1 (ko) 2005-04-25
MXPA02006699A (es) 2005-08-16
NO322966B1 (no) 2006-12-18
EA005160B1 (ru) 2004-12-30
PL355034A1 (en) 2003-01-13
KR20030007159A (ko) 2003-01-23
NO20023345D0 (no) 2002-07-11
CA2394027A1 (fr) 2003-01-12
FR2827288A1 (fr) 2003-01-17
JP2003064081A (ja) 2003-03-05
ATE254124T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
WO2003087094A3 (en) Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
BR0016396A (pt) Novos antagonistas do receptor p2x7 para uso no tratamento de doenças inflamatórias, imunes ou cardiovasculares
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
NO20015379D0 (no) Indolinderivater som progesteronantagonister
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
NO20026094D0 (no) Fusjonerte azepinderivater og deres anvendelse som antidiuretiske midler
PT1206473E (pt) Pirrolocarbazoles e isoindolonas fundidos isomericos
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
BRPI0415015A (pt) certas lactamas espirocìclicas substituìdas e uso destas como produtos farmacêuticos
SE9702773D0 (sv) Novel compounds
DE60220258D1 (de) Derivate von quinolyl-propyl-piperidine, deren herstellung und die sie enthaltenden zusamensetzungen
NO20035772L (no) Oksytocinagonister
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
WO2004112704A3 (en) Substituted piperidine compounds and methods of their use
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DE60112325D1 (de) Cyclisierungsverfahrensschritt bei der herstellung von chinolonen und naphthyridinen
MXPA02012015A (es) Ligandos de receptores para integrinas.
FR2827288B1 (fr) Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
BR0000850B1 (pt) mistura de 3-metiloct-6-enóis 6-substituìdos, composição adorante contendo a referida mistura, bem como seu uso.